Neumora Therapeutics, Inc. Financial Overview
Neumora Therapeutics, Inc.'s market cap is currently $309.11M. The company's EPS TTM is $-0.35; its P/E ratio is -1.26; Neumora Therapeutics, Inc. is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.33. See an overview of income statement, balance sheet, and cash flow financials.
